Physician

Ryan M Tarantola, MD

According to 2025 Medicare claims, Ryan Tarantola, MD (NPI: 1316094139) practices ophthalmology in the Crestview-Fort Walton Beach-Destin, FL market, with the plurality of this provider's patient population coming from Okaloosa, FL. This provider's primary affiliated billing organization is SUNIL GUPTA MD LLC (NPI: 1588610075; TIN: 593482386) and primary practice location at 32547-1319.

Tarantola's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,736 traditional Medicare patients, billed 83,872 HCPCS/CPT codes, and received $6,597,176 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 697 prescription claims across 212 beneficiaries totaling $52,132 in drug costs, led by Travoprost (Travoprost). Open Payments data shows 17 records totaling $761. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,825,835 to $6,597,176. Similarly, Part D prescription costs have risen steadily, from $36,413 to $52,132. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.3M$6.6M2015 Medicare payment: $1,825,835 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,121,686 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,165,652 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,336,217 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,023,483 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,997,103 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,530,933 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,649,019 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,520,449 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,597,176 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,36014,965$1,825,835
20161,44316,847$2,121,686
20171,51316,500$2,165,652
20181,60416,797$2,336,217
20191,52517,164$3,023,483
20201,41015,727$3,997,103
20211,47418,289$4,530,933
20221,61321,764$4,649,019
20231,59142,178$5,520,449
20241,73683,872$6,597,176

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$32K$63K2015 Drug cost: $36,413 (USD; Tot_Drug_Cst)2016 Drug cost: $29,311 (USD; Tot_Drug_Cst)2017 Drug cost: $42,302 (USD; Tot_Drug_Cst)2018 Drug cost: $55,122 (USD; Tot_Drug_Cst)2019 Drug cost: $54,632 (USD; Tot_Drug_Cst)2020 Drug cost: $63,170 (USD; Tot_Drug_Cst)2021 Drug cost: $61,849 (USD; Tot_Drug_Cst)2022 Drug cost: $45,605 (USD; Tot_Drug_Cst)2023 Drug cost: $57,301 (USD; Tot_Drug_Cst)2024 Drug cost: $52,132 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015124385$36,413
2016113372$29,311
2017137432$42,302
2018148514$55,122
2019144527$54,632
2020150513$63,170
2021157518$61,849
2022152480$45,605
2023179582$57,301
2024212697$52,132

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye7083,448$97
92014Established patient complete exam of visual system7812,308$92
92012Established patient problem focused exam of visual system8191,653$64
92134Imaging of retina1,4143,990$31
92202Extended exam of the back part of the eye with optic nerve drawing403420$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TravoprostTravoprost442,561$7,009
LumiganBimatoprost21744$6,981
DifluprednateDifluprednate571,411$6,119
Prednisolone AcetatePrednisolone Acetate983,249$6,004
IlevroNepafenac13720$5,266

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$761Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ryan M. Tarantola, MD?

Tedicare shows public-source Medicare data for Ryan M. Tarantola, MD (NPI 1316094139), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan M. Tarantola, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan M. Tarantola, MD?

Ryan M. Tarantola, MD is linked to SUNIL GUPTA MD LLC (billing NPI 1588610075) in the available physician profile data.

Does Ryan M. Tarantola, MD have Open Payments data?

Ryan M. Tarantola, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.